Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Smooth endoplasmic reticulum aggregates in human oocytes are related to female infertility etiology and diminished reproductive outcomes

N. Ghanami Gashti, SZ. Hosseini, M. Qasemi, R. Kabodmehri, Z. Zahiri Sorouri, MH. Bahadori

. 2025 ; 15 (1) : 7160. [pub] 20250228

Language English Country England, Great Britain

Document type Journal Article

Smooth endoplasmic reticulum aggregates (SERa) are a type of dysmorphism in oocytes derived from controlled ovarian stimulation (COS). The effect of SERa on assisted reproductive techniques (ART) outcomes is debatable. Based on some evidence, SERa-positive (SERa+) oocytes cause complications including newborn demise, and compromise the outcome of the unaffected oocytes of the same cycle. While other reports demonstrated equal developmental competence between SERa + and SERa-negative (SERa-) oocytes/cycles. We conducted a prospective cross-sectional study on 315 women candidates for ART and compared the outcome among SERa+ (N = 73) and SERa- cycles (N = 217). Furthermore, for the first time, we investigated the prevalence of SERa + cycles in women with various infertility etiologies. Our results indicated that SERa + patients presented higher levels of Estradiol on the day of ovulation triggering (p = 0.02). Regarding the ART outcome, there were no differences in the number of retrieved oocytes, oocyte maturation and fertilization rates among the groups. However, the quality of the unaffected oocytes (p = 0.03), the rates of day-3 top-quality embryos (p = 0.01, and p = 0.03 for grades A and B, respectively), and clinical pregnancy (p = 0.05) in SERa + group were significantly reduced. Moreover, the prevalence of SERa + cycles gradually increased among endometriosis, POI/POR, PCOS, normal women, tubal factor, and idiopathic groups. Our study suggests that suboptimal situations such as elevated levels of Estradiol can increase the occurrence of SERa + oocytes. This suboptimal phenomenon can negatively influence the outcome of the cycle. Thus, optimization of COS, particularly in vulnerable groups such as women with idiopathic infertility may lower the SERa + cycle occurrence, improving the ART outcome.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009785
003      
CZ-PrNML
005      
20250429135311.0
007      
ta
008      
250415s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-024-78366-7 $2 doi
035    __
$a (PubMed)40021655
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Ghanami Gashti, Nasrin $u Biomaterials Cluster, Bernal Institute, University of Limerick, Limerick, Ireland $u School of Engineering, University of Limerick, Limerick, Ireland
245    10
$a Smooth endoplasmic reticulum aggregates in human oocytes are related to female infertility etiology and diminished reproductive outcomes / $c N. Ghanami Gashti, SZ. Hosseini, M. Qasemi, R. Kabodmehri, Z. Zahiri Sorouri, MH. Bahadori
520    9_
$a Smooth endoplasmic reticulum aggregates (SERa) are a type of dysmorphism in oocytes derived from controlled ovarian stimulation (COS). The effect of SERa on assisted reproductive techniques (ART) outcomes is debatable. Based on some evidence, SERa-positive (SERa+) oocytes cause complications including newborn demise, and compromise the outcome of the unaffected oocytes of the same cycle. While other reports demonstrated equal developmental competence between SERa + and SERa-negative (SERa-) oocytes/cycles. We conducted a prospective cross-sectional study on 315 women candidates for ART and compared the outcome among SERa+ (N = 73) and SERa- cycles (N = 217). Furthermore, for the first time, we investigated the prevalence of SERa + cycles in women with various infertility etiologies. Our results indicated that SERa + patients presented higher levels of Estradiol on the day of ovulation triggering (p = 0.02). Regarding the ART outcome, there were no differences in the number of retrieved oocytes, oocyte maturation and fertilization rates among the groups. However, the quality of the unaffected oocytes (p = 0.03), the rates of day-3 top-quality embryos (p = 0.01, and p = 0.03 for grades A and B, respectively), and clinical pregnancy (p = 0.05) in SERa + group were significantly reduced. Moreover, the prevalence of SERa + cycles gradually increased among endometriosis, POI/POR, PCOS, normal women, tubal factor, and idiopathic groups. Our study suggests that suboptimal situations such as elevated levels of Estradiol can increase the occurrence of SERa + oocytes. This suboptimal phenomenon can negatively influence the outcome of the cycle. Thus, optimization of COS, particularly in vulnerable groups such as women with idiopathic infertility may lower the SERa + cycle occurrence, improving the ART outcome.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    12
$a oocyty $7 D009865
650    12
$a ženská infertilita $x patologie $x etiologie $7 D007247
650    _2
$a dospělí $7 D000328
650    12
$a hladké endoplazmatické retikulum $x metabolismus $7 D018871
650    _2
$a těhotenství $7 D011247
650    _2
$a průřezové studie $7 D003430
650    12
$a indukce ovulace $x škodlivé účinky $7 D010062
650    _2
$a prospektivní studie $7 D011446
650    _2
$a asistovaná reprodukce $x škodlivé účinky $7 D027724
650    _2
$a úhrn těhotenství na počet žen v reprodukčním věku $7 D018873
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hosseini, Seyedeh Zahra $u Reproductive Health Research Center (IVF Center), Al-Zahra Educational and Remedial Center, Guilan University of Medical Sciences, Rasht, Iran
700    1_
$a Qasemi, Maryam $u Laboratory of Reproductive Biology, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Prumyslova 595, Vestec, 252 50, Czech Republic. Maryam.Qasemi@ibt.cas.cz
700    1_
$a Kabodmehri, Roya $u Reproductive Health Research Center, Department of Obstetrics and Gynecology, School of Medicine, Al-Zahra Hospital, Guilan University of Medical Sciences, Rasht, Iran
700    1_
$a Zahiri Sorouri, Ziba $u Reproductive Health Research Center, Department of Obstetrics and Gynecology, School of Medicine, Al-Zahra Hospital, Guilan University of Medical Sciences, Rasht, Iran
700    1_
$a Bahadori, Mohammad Hadi $u Cellular and Molecular Research Center, Guilan University of Medical Sciences, Rasht, Iran
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 15, č. 1 (2025), s. 7160
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40021655 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135307 $b ABA008
999    __
$a ok $b bmc $g 2311271 $s 1246866
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 15 $c 1 $d 7160 $e 20250228 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...